Innovative approaches to treat steroid-resistant or steroid refractory GVHD. Read more about Innovative approaches to treat steroid-resistant or steroid refractory GVHD.
New classification of chronic GVHD: added clarity from the consensus diagnoses. Read more about New classification of chronic GVHD: added clarity from the consensus diagnoses.
Impact of intensive PBSC mobilization therapy on outcomes following auto-SCT for non-Hodgkin's lymphoma. Read more about Impact of intensive PBSC mobilization therapy on outcomes following auto-SCT for non-Hodgkin's lymphoma.
Prospective single-arm study of pegfilgrastim activity and safety in children with poor-risk malignant tumours receiving chemotherapy. Read more about Prospective single-arm study of pegfilgrastim activity and safety in children with poor-risk malignant tumours receiving chemotherapy.
Increasing mixed chimerism and the risk of graft loss in children undergoing allogeneic hematopoietic stem cell transplantation for non-malignant disorders. Read more about Increasing mixed chimerism and the risk of graft loss in children undergoing allogeneic hematopoietic stem cell transplantation for non-malignant disorders.
Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial. Read more about Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial.
Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future. Read more about Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future.
Hematopoietic stem cell transplantation for primary immunodeficiency disease. Read more about Hematopoietic stem cell transplantation for primary immunodeficiency disease.
Inhaled corticosteroids stabilize constrictive bronchiolitis after hematopoietic stem cell transplantation. Read more about Inhaled corticosteroids stabilize constrictive bronchiolitis after hematopoietic stem cell transplantation.
Lymphocyte subsets recovery following allogeneic bone marrow transplantation (BMT): CD4+ cell count and transplant-related mortality. Read more about Lymphocyte subsets recovery following allogeneic bone marrow transplantation (BMT): CD4+ cell count and transplant-related mortality.
